survival in mantle cell lymphoma mRNAs that are associated with increased proliferation rate and shorter Point mutations and genomic deletions in Cyclin D1 create stable truncated

[1]  R. Vartanian,et al.  Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling , 2006, Oncogene.

[2]  Z. Estrov,et al.  Z-138 cell line was derived from a patient with blastoid variant mantle cell lymphoma. , 2006, Leukemia research.

[3]  C. Haiman,et al.  Cyclin D1: polymorphism, aberrant splicing and cancer risk , 2006, Oncogene.

[4]  P. Dubus,et al.  Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features , 2006, Histopathology.

[5]  C. Haiman,et al.  Cyclin D1b variant influences prostate cancer growth through aberrant androgen receptor regulation , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Burge,et al.  The Widespread Impact of Mammalian MicroRNAs on mRNA Repression and Evolution , 2005, Science.

[7]  R. Fonseca,et al.  Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  K. Gunsalus,et al.  Combinatorial microRNA target predictions , 2005, Nature Genetics.

[9]  K. Lindblad-Toh,et al.  Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals , 2005, Nature.

[10]  J. Castle,et al.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.

[11]  D. Bartel,et al.  Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs , 2004, Nature Reviews Genetics.

[12]  J. Diehl,et al.  An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. , 2003, Cancer research.

[13]  A. Senderowicz,et al.  Cyclin D1 Splice Variants , 2003, Journal of Biological Chemistry.

[14]  G. Stoecklin,et al.  A novel mechanism of tumor suppression by destabilizing AU-rich growth factor mRNA , 2003, Oncogene.

[15]  S. Capaccioli,et al.  Post‐transcriptional regulation of gene expression by degradation of messenger RNAs , 2003, Journal of cellular physiology.

[16]  L. Staudt,et al.  The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.

[17]  J. Rastad,et al.  The NciI polymorphism in the cyclin D1 gene and sporadic primary hyperparathyroidism , 2001, Journal of internal medicine.

[18]  M. Mann,et al.  AU Binding Proteins Recruit the Exosome to Degrade ARE-Containing mRNAs , 2001, Cell.

[19]  V Jahnke,et al.  Cyclin D1 polymorphism and expression in patients with squamous cell carcinoma of the head and neck. , 2001, The American journal of pathology.

[20]  Andreas Rosenwald,et al.  Genomic-scale measurement of mRNA turnover and the mechanisms of action of the anti-cancer drug flavopiridol , 2001, Genome Biology.

[21]  J. Guhaniyogi,et al.  Regulation of mRNA stability in mammalian cells. , 2001, Gene.

[22]  J. Taubenberger,et al.  Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma. , 2001, Clinical chemistry.

[23]  G. M. Wilson,et al.  Down-Regulation of Cyclin D1 Expression by Prostaglandin A2 Is Mediated by Enhanced Cyclin D1 mRNA Turnover , 2000, Molecular and Cellular Biology.

[24]  M. Seto,et al.  A small deletion in the 3′‐untranslated region of the cyclin D1/ PRAD1/ bcl‐1 oncogene in a patient with chronic lymphocytic leukemia , 1998, International journal of cancer.

[25]  A. López-Guillermo,et al.  Mantle cell lymphoma , 1998, Seminars in hematology.

[26]  E. Schmidt,et al.  Cyclin D1 (PRAD1) alternative transcript b: full-length cDNA cloning and expression in breast cancers. , 1997, Cancer letters.

[27]  D. Gerhard,et al.  Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. , 1996, Blood.

[28]  C. Y. Chen,et al.  AU-rich elements: characterization and importance in mRNA degradation. , 1995, Trends in biochemical sciences.

[29]  N Thatcher,et al.  Alternate splicing produces a novel cyclin D1 transcript. , 1995, Oncogene.

[30]  Y. Hosokawa,et al.  Absence of cyclin D1/PRAD1 point mutations in human breast cancers and parathyroid adenomas and identification of a new cyclin D1 gene polymorphism. , 1995, Cancer letters.

[31]  A. López-Guillermo,et al.  PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma , 1994 .

[32]  N. Rosen,et al.  A truncated cyclin D1 gene encodes a stable mRNA in a human breast cancer cell line. , 1994, Oncogene.

[33]  B. Klein,et al.  Rearrangement of CCND1 (BCL1/PRAD1) 3' untranslated region in mantle-cell lymphomas and t(11q13)-associated leukemias. , 1994, Blood.

[34]  H. Hirsch,et al.  Cyclosporin A inhibits growth of autocrine tumour cell lines by destabilizing interleukin-3 mRNA , 1994, Nature.

[35]  B. Klein,et al.  Expanded range of 11q13 breakpoints with differing patterns of cyclin D1 expression in B‐cell malignancies , 1993, Genes, chromosomes & cancer.

[36]  Charles J. Sherr,et al.  Mammalian G1 cyclins , 1993, Cell.

[37]  K. Scotto,et al.  Differential utilization of poly (A) signals between DHFR alleles in CHL cells. , 1992, Nucleic acids research.

[38]  Y. Akao,et al.  Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation. , 1992, Oncogene.

[39]  O. Melnyk,et al.  Characterization of a candidate bcl-1 gene , 1991, Molecular and cellular biology.

[40]  M. Raffeld,et al.  bcl-1, t(11;14), and mantle cell-derived lymphomas. , 1991, Blood.

[41]  B. Futcher,et al.  Human D-type cyclin , 1991, Cell.

[42]  S. Swerdlow,et al.  Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. , 1990, Blood.

[43]  S. Swerdlow,et al.  From centrocytic to mantle cell lymphoma: a clinicopathologic and molecular review of 3 decades. , 2002, Human pathology.

[44]  C. Lynas,et al.  The cyclin D1 alternative transcripts [a] and [b] are expressed in normal and malignant lymphocytes and their relative levels are influenced by the polymorphism at codon 241. , 2001, Haematologica.